Israel Discount Bank of New York’s United Therapeutics UTHR Stock Holding History

Israel Discount Bank of New York’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-320	Closed	-$38K	–	347
2019 Q1	$38K	Hold	320	–	–	0.03%	261
2018 Q4	$35K	Hold	320	–	–	0.03%	259
2018 Q3	$41K	Buy	320 +30	+10%	+$3.71K	0.03%	252
2018 Q2	$33K	Hold	290	–	–	0.02%	339
2018 Q1	$33K	Hold	290	–	–	0.02%	341
2017 Q4	$43K	Sell	290 -25	-8%	-$3.18K	0.03%	305
2017 Q3	$37K	Hold	315	–	–	0.03%	323
2017 Q2	$41K	Hold	315	–	–	0.03%	298
2017 Q1	$43K	Sell	315 -5	-2%	-$757	0.04%	285
2016 Q4	$46K	Buy	+320	New	+$40.9K	0.04%	274

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Israel Discount Bank of New York's UTHR Position: Q2 2019 in Review

Israel Discount Bank of New York sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 320 shares — an estimated $38K sold.

Israel Discount Bank of New York first reported a position in UTHR in Q4 2016 and held it in 10 quarters. The position peaked at $46K in Q4 2016. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

Israel Discount Bank of New York reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
Israel Discount Bank of New York sold 320 United Therapeutics shares in Q2 2019, an estimated $38K.
Israel Discount Bank of New York first reported a position in United Therapeutics in Q4 2016 and held it in 10 quarters.
Israel Discount Bank of New York's United Therapeutics position peaked at $46K in Q4 2016.
320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on Israel Discount Bank of New York's 13F filing for Q2 2019, filed 14 Aug 2019.